BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 11802587)

  • 41. The science of evaluation of adverse events associated with vaccination.
    Halsey NA
    Semin Pediatr Infect Dis; 2002 Jul; 13(3):205-14. PubMed ID: 12199617
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The complicated task of monitoring vaccine safety.
    Ellenberg SS; Chen RT
    Public Health Rep; 1997; 112(1):10-20; discussion 21. PubMed ID: 9018282
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combination vaccines: postlicensure safety evaluation.
    Chen RT; Pool V; Takahashi H; Weniger BG; Patel B
    Clin Infect Dis; 2001 Dec; 33 Suppl 4():S327-33. PubMed ID: 11709768
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vaccine adverse events in the new millennium: is there reason for concern?
    Ward BJ
    Bull World Health Organ; 2000; 78(2):205-15. PubMed ID: 10743286
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vaccination, seizures and 'vaccine damage'.
    Brown NJ; Berkovic SF; Scheffer IE
    Curr Opin Neurol; 2007 Apr; 20(2):181-7. PubMed ID: 17351489
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Application of the immunological disease continuum to study autoimmune and other inflammatory events after vaccination.
    Koenig HC; Sutherland A; Izurieta HS; McGonagle D
    Vaccine; 2011 Jan; 29(5):913-9. PubMed ID: 21036134
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biologically plausible and evidence-based risk intervals in immunization safety research.
    Rowhani-Rahbar A; Klein NP; Dekker CL; Edwards KM; Marchant CD; Vellozzi C; Fireman B; Sejvar JJ; Halsey NA; Baxter R;
    Vaccine; 2012 Dec; 31(1):271-7. PubMed ID: 22835735
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Challenges and controversies in immunization safety.
    Chen RT; DeStefano F; Pless R; Mootrey G; Kramarz P; Hibbs B
    Infect Dis Clin North Am; 2001 Mar; 15(1):21-39, viii. PubMed ID: 11301817
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Confounding in studies of adverse reactions to vaccines.
    Fine PE; Chen RT
    Am J Epidemiol; 1992 Jul; 136(2):121-35. PubMed ID: 1415136
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The challenge of vaccine safety.
    Jacobson RM; Zabel KS; Poland GA
    Semin Pediatr Infect Dis; 2002 Jul; 13(3):215-20. PubMed ID: 12199618
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Vaccine complications].
    Bourquin C; Zimmermann HP; Desgrandchamps D; Kuhn M
    Rev Med Suisse Romande; 1998 Apr; 118(4):363-70. PubMed ID: 9623289
    [No Abstract]   [Full Text] [Related]  

  • 52. Drug interactions involving immunologic agents. Part I. Vaccine-vaccine, vaccine-immunoglobulin, and vaccine-drug interactions.
    Grabenstein JD
    DICP; 1990 Jan; 24(1):67-81. PubMed ID: 2405589
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Childhood vaccines: how safe are they?
    Mera KE; Hackley B
    Am J Nurs; 2003 Feb; 103(2):79, 81, 83-4, 86, 88. PubMed ID: 12582345
    [No Abstract]   [Full Text] [Related]  

  • 54. Vaccine trials.
    Farrington CP; Miller E
    Mol Biotechnol; 2001 Jan; 17(1):43-58. PubMed ID: 11280930
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Understanding the host-pathogen interaction saves lives: lessons from vaccines and vaccinations.
    Garon JR; Orenstein WA
    Curr Opin Immunol; 2015 Oct; 36():8-13. PubMed ID: 25974089
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesising licensing data to assess drug safety.
    McPherson K; Hemminki E
    BMJ; 2004 Feb; 328(7438):518-20. PubMed ID: 14988197
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Do we truly understand vaccine reactions and vaccinosis?
    Saxton JG
    Homeopathy; 2005 Jul; 94(3):200-1. PubMed ID: 16060206
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of epidemiology in vaccine policy.
    Begg N; Miller E
    Vaccine; 1990 Jun; 8(3):180-9. PubMed ID: 2194378
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Considerations for unblinding individual study participants during vaccine trials.
    Halsey N; Evans S; Santosham M; Hacker A; Edwards KM; Chandler RE; Dudley MZ; Dekker CL; ; Al-Abri S; Arora N; Buttery J; Dodoo A; Eskola J; Heininger U; Jee Y; Khuri N; Obaro S; Orenstein W; Pitisuttithum P; Safadi M; Whitney CG; Black S
    Vaccine; 2023 May; 41(22):3399-3402. PubMed ID: 37121805
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Roots of vaccine hesitancy.
    Marshall GS
    S D Med; 2013; Spec no():52-7. PubMed ID: 23444592
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.